{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:16:54Z","timestamp":1793236614368,"version":"4.5.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK052574"],"award-info":[{"award-number":["P30DK052574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U2CCA271895"],"award-info":[{"award-number":["U2CCA271895"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA271079"],"award-info":[{"award-number":["U24CA271079"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.trecan.2025.04.011","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:33:06Z","timestamp":1748302386000},"page":"753-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Harnessing technologies to unravel gastric cancer heterogeneity"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5731-6143","authenticated-orcid":false,"given":"Yuefan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon U.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1447-4979","authenticated-orcid":false,"given":"Ding Chiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing K.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2025.04.011_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.trecan.2025.04.011_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2025.04.011_bb0015","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.trecan.2025.04.011_bb0020","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2020.07.049","article-title":"Population-based analysis of differences in gastric cancer incidence among races and ethnicities in individuals age 50 years and older","volume":"159","author":"Shah","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2025.04.011_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41571-023-00767-w","article-title":"Early stage gastric adenocarcinoma: clinical and molecular landscapes","volume":"20","author":"Hirata","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-021-00412-7","article-title":"Mapping the genomic diaspora of gastric cancer","volume":"22","author":"Yeoh","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/cpmb.59","article-title":"Overview of next-generation sequencing technologies","volume":"122","author":"Slatko","year":"2018","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0060","first-page":"997","article-title":"Next-generation sequencing technology: current trends and advancements","volume":"12","author":"Satam","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.trecan.2025.04.011_bb0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0039-1688446","article-title":"Next-generation sequencing and emerging technologies","volume":"45","author":"Kumar","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.trecan.2025.04.011_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.04.011_bb0075","series-title":"Inflammation and Cancer: Methods and Protocols","first-page":"165","article-title":"DNA methylation analysis","author":"Hattori","year":"2023"},{"key":"10.1016\/j.trecan.2025.04.011_bb0080","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21856","article-title":"An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites","volume":"6","author":"Skene","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.trecan.2025.04.011_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg2641","article-title":"ChIP-seq: advantages and challenges of a maturing technology","volume":"10","author":"Park","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymeth.2020.03.005","article-title":"Methods for ChIP-seq analysis: a practical workflow and advanced applications","volume":"187","author":"Nakato","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.trecan.2025.04.011_bb0095","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cell.2021.02.055","article-title":"The next horizon in precision oncology: proteogenomics to inform cancer diagnosis and treatment","volume":"184","author":"Rodriguez","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0100","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Proteogenomic characterization of pancreatic ductal adenocarcinoma","volume":"184","author":"Cao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0105","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1016\/j.cell.2023.07.013","article-title":"Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation","volume":"186","author":"Geffen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2025.04.011_bb0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature01511","article-title":"Mass spectrometry-based proteomics","volume":"422","author":"Aebersold","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.011_bb0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-022-00446-5","article-title":"Cancer proteogenomics: current impact and future prospects","volume":"22","author":"Mani","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","article-title":"Proteogenomic characterization of human early-onset gastric cancer","volume":"35","author":"Mun","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0130","first-page":"377","article-title":"Lymphoepithelial carcinoma of the stomach with Epstein\u2013Barr virus demonstrated by polymerase chain reaction","volume":"3","author":"Burke","year":"1990","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0135","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrgastro.2014.99","article-title":"Helicobacter pylori: perspectives and time trends","volume":"11","author":"Malfertheiner","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/mr.51.2.221-271.1987","article-title":"Bacterial evolution","volume":"51","author":"Woese","year":"1987","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.trecan.2025.04.011_bb0145","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CMR.17.4.840-862.2004","article-title":"Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases","volume":"17","author":"Clarridge","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.trecan.2025.04.011_bb0150","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/19490976.2020.1762520","article-title":"The role of gastric microbiota in gastric cancer","volume":"11","author":"Stewart","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.trecan.2025.04.011_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","article-title":"The gut mycobiome of the Human Microbiome Project healthy cohort","volume":"5","author":"Nash","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.trecan.2025.04.011_bb0160","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1093\/bioinformatics\/bty501","article-title":"GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts","volume":"34","author":"Walker","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0165","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","article-title":"A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors","volume":"185","author":"Dohlman","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0170","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.ccell.2023.10.004","article-title":"Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression","volume":"41","author":"Huang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0180","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","article-title":"Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices","volume":"18","author":"Alseekh","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2025.04.011_bb0185","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-021-04396-y","article-title":"Interactions between gastric microbiota and metabolites in gastric cancer","volume":"12","author":"Dai","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.04.011_bb0190","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41576-023-00599-5","article-title":"Single-cell genomics meets human genetics","volume":"24","author":"Cuomo","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0195","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41576-023-00628-3","article-title":"A focus on single-cell omics","volume":"24","author":"Anon.","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","article-title":"Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0210","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","article-title":"Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer","volume":"12","author":"Kumar","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.04.011_bb0215","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","article-title":"Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.011_bb0220","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3892\/ol.2024.14285","article-title":"Applications of single-cell omics and spatial transcriptomics technologies in gastric cancer (Review)","volume":"27","author":"Ren","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.trecan.2025.04.011_bb0225","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/2159-8290.CD-24-0605","article-title":"Spatially resolved tumor ecosystems and cell states in gastric adenocarcinoma progression and evolution","volume":"15","author":"Ma","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.04.011_bb0230","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0235","article-title":"Joint single cell DNA-seq and RNA-seq of gastric cancer cell lines reveals rules of in vitro evolution","volume":"2","author":"Andor","year":"2020","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.trecan.2025.04.011_bb0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ccell.2023.06.005","article-title":"Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0245","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","article-title":"Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states","volume":"39","author":"Simeonov","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0250","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.cell.2022.04.015","article-title":"Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution","volume":"185","author":"Yang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad094","article-title":"Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer","volume":"10","author":"Bian","year":"2023","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.trecan.2025.04.011_bb0260","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000227074","article-title":"Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer","volume":"49","author":"Yonemura","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0265","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41588-023-01333-x","article-title":"Multiancestry genomic and transcriptomic analysis of gastric cancer","volume":"55","author":"Totoki","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0270","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"The Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.011_bb0275","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0280","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/2159-8290.CD-19-0487","article-title":"Genomics and targeted therapies in gastroesophageal adenocarcinoma","volume":"9","author":"Nagaraja","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.04.011_bb0285","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0290","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","article-title":"Comparative molecular analysis of gastrointestinal adenocarcinomas","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0295","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0300","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2159-8290.CD-19-0811","article-title":"Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.04.011_bb0305","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41467-018-04907-0","article-title":"Prognostic significance of frequent CLDN18-ARHGAP26\/6 fusion in gastric signet-ring cell cancer","volume":"9","author":"Shu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.011_bb0310","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","article-title":"Claudin 18.2 as a novel therapeutic target","volume":"21","author":"Nakayama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0315","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/s44321-024-00120-3","article-title":"Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer","volume":"16","author":"Wang","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0320","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","article-title":"Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer","volume":"86","author":"Zeng","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0325","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.celrep.2019.04.052","article-title":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer","volume":"27","author":"Zhang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.04.011_bb0330","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","article-title":"A proteomic landscape of diffuse-type gastric cancer","volume":"9","author":"Ge","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.011_bb0335","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41467-023-35797-6","article-title":"Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.011_bb0340","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1158\/1078-0432.CCR-16-2211","article-title":"Clinical significance of four molecular subtypes of gastric cancer identified by The Cancer Genome Atlas Project","volume":"23","author":"Sohn","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0345","article-title":"Comprehensive review on the clinical impact of next-generation sequencing tests for the management of advanced cancer","volume":"7","author":"Gibbs","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0350","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1007\/s00018-018-2906-9","article-title":"Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches","volume":"75","author":"Ratti","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.trecan.2025.04.011_bb0355","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1538-7445.AM2024-1851","article-title":"Abstract 1851: comprehensive multi-level proteomics characterization of gastric cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb2005","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1158\/1538-7445.AM2025-7474","article-title":"Abstract 7474: Comprehensive multi-omics characterization of gastric cancers with proteogenomic insights","volume":"85","author":"Olsen","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0360","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2025.04.011_bb0365","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.trecan.2025.04.011_bb0370","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ebiom.2018.12.034","article-title":"Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer","volume":"40","author":"Liu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trecan.2025.04.011_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.07.004","article-title":"Microbial carcinogenesis: lactic acid bacteria in gastric cancer","volume":"1872","author":"Vinasco","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0380","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","article-title":"Mucosal microbiome dysbiosis in gastric carcinogenesis","volume":"67","author":"Coker","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2025.04.011_bb0385","article-title":"Diversification and deleterious role of microbiome in gastric cancer","volume":"6","author":"Chattopadhyay","year":"2023","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.trecan.2025.04.011_bb0390","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2024.01.004","article-title":"Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice","volume":"187","author":"Fu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0395","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2025.04.011_bb0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","article-title":"Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study","volume":"158","author":"Kumar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0405","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/j.gastro.2023.04.026","article-title":"Effect of Helicobacter pylori eradication therapy on the incidence of noncardia gastric adenocarcinoma in a large diverse population in the United States","volume":"165","author":"Li","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0410","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori Therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Choi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0415","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3812","article-title":"Anti-Helicobacter pylori treatment in patients with gastric cancer after radical gastrectomy","volume":"7","author":"Zhao","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.trecan.2025.04.011_bb0420","doi-asserted-by":"crossref","first-page":"79604","DOI":"10.18632\/oncotarget.18758","article-title":"Positive Helicobacter pylori status is associated with better overall survival for gastric cancer patients: evidence from case-cohort studies","volume":"8","author":"Fang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2025.04.011_bb0425","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007699","article-title":"Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors","volume":"11","author":"Magahis","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0430","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41419-022-05350-2","article-title":"Liquid biopsy in gastric cancer: predictive and prognostic biomarkers","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.04.011_bb0435","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1078-0432.CCR-13-2664","article-title":"Circulating tumor cells: a multifunctional biomarker","volume":"20","author":"Yap","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0440","article-title":"Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer","volume":"12","author":"Kang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2025.04.011_bb0445","first-page":"3083","article-title":"Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay","volume":"34","author":"Vaiopoulos","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: a broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0455","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.3390\/cancers14205105","article-title":"The role of ctDNA in gastric cancer","volume":"14","author":"Mencel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2025.04.011_bb0460","doi-asserted-by":"crossref","first-page":"54037","DOI":"10.18632\/oncotarget.11079","article-title":"Alu-based cell-free DNA: a novel biomarker for screening of gastric cancer","volume":"8","author":"Qian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2025.04.011_bb0465","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000403","article-title":"Liquid biopsy in gastric cancer: analysis of somatic cancer tissue mutations in plasma cell-free DNA for predicting disease state and patient survival","volume":"12","author":"Varkalaite","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0470","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.18632\/oncotarget.13821","article-title":"Clinical relevance of cell-free DNA in gastrointestinal tract malignancy","volume":"8","author":"Lan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2025.04.011_bb0475","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41419-020-2531-z","article-title":"Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.04.011_bb0480","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-05-2821","article-title":"Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival","volume":"12","author":"Hayes","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0485","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0490","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer","volume":"14","author":"de Bono","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0495","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0500","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa2304714","article-title":"A Cell-free DNA blood-based test for colorectal cancer screening","volume":"390","author":"Chung","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0505","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2025.04.011_bb0510","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1470-2045(23)00277-2","article-title":"Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study","volume":"24","author":"Nicholson","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0515","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2020.06.022","article-title":"Non-coding RNAs in gastric cancer","volume":"493","author":"Xie","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2025.04.011_bb0520","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.7150\/thno.47548","article-title":"Long non-coding RNAs in gastric cancer: new emerging biological functions and therapeutic implications","volume":"10","author":"Tan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0525","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2025.04.011_bb0530","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","article-title":"Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)","volume":"262","author":"Johnstone","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2025.04.011_bb0535","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-019-1001-7","article-title":"Exosomes in gastric cancer: roles, mechanisms, and applications","volume":"18","author":"Fu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0540","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12672-024-01024-x","article-title":"Harnessing exosomes in theranostic applications: advancements and insights in gastrointestinal cancer research","volume":"15","author":"Shojaeian","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0545","article-title":"Non-coding RNAs and extracellular vehicles: their role in the pathogenesis of gestational diabetes mellitus","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.trecan.2025.04.011_bb0550","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0555","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41596-021-00566-6","article-title":"Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation","volume":"16","author":"Nakayasu","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2025.04.011_bb0560","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molmed.2013.07.003","article-title":"Gastric cancer: adding glycosylation to the equation","volume":"19","author":"Pinho","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106420","article-title":"The role and potential mechanism of O-Glycosylation in gastrointestinal tumors","volume":"184","author":"Zhou","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316931","article-title":"Circulating proteins as diagnostic markers in gastric cancer","volume":"24","author":"Repetto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2025.04.011_bb0575","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14789450.2020.1740091","article-title":"Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians","volume":"17","author":"Jeong","year":"2020","journal-title":"Expert. Rev. Proteom."},{"key":"10.1016\/j.trecan.2025.04.011_bb0580","doi-asserted-by":"crossref","first-page":"25957","DOI":"10.1038\/srep25957","article-title":"Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.04.011_bb0585","doi-asserted-by":"crossref","first-page":"35718","DOI":"10.18632\/oncotarget.16082","article-title":"Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer","volume":"8","author":"Shu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2025.04.011_bb0590","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/biom6030033","article-title":"Mucin-type O-glycosylation in gastric carcinogenesis","volume":"6","author":"Duarte","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.trecan.2025.04.011_bb0595","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2009.01.024","article-title":"Role of E-cadherin N-glycosylation profile in a mammary tumor model","volume":"379","author":"Pinho","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.trecan.2025.04.011_bb0600","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.bbagen.2012.10.021","article-title":"E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V","volume":"1830","author":"Pinho","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.trecan.2025.04.011_bb0605","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2019.12.004","article-title":"Histologic subtyping of gastric intestinal metaplasia: overview and considerations for clinical practice","volume":"158","author":"Shah","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0610","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1440-1746.2003.02998.x","article-title":"Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma","volume":"18","author":"Chan","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0615","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1158\/0008-5472.CAN-08-2457","article-title":"E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man","volume":"69","author":"Humar","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0620","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0625","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.trecan.2025.04.011_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188549","article-title":"HER2-targeted therapies in gastric cancer","volume":"1876","author":"Zhu","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0635","doi-asserted-by":"crossref","first-page":"750","DOI":"10.21037\/jgo.2016.06.10","article-title":"The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond","volume":"7","author":"Kelly","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0640","doi-asserted-by":"crossref","first-page":"16649","DOI":"10.1002\/cam4.6269","article-title":"Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial","volume":"12","author":"Hu","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0645","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1038\/s41467-022-33282-0","article-title":"Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.011_bb0650","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41420-022-01259-z","article-title":"Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.04.011_bb0655","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41416-023-02559-6","article-title":"Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer","volume":"130","author":"Wang","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0660","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0665","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","article-title":"Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial","volume":"17","author":"Muro","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0670","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2025.04.011_bb0675","doi-asserted-by":"crossref","first-page":"14027","DOI":"10.1038\/s41598-024-63486-x","article-title":"Plasma circulating tumor DNA unveils the efficacy of PD-1 inhibitors and chemotherapy in advanced gastric cancer","volume":"14","author":"Jiang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.04.011_bb0680","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.34366","article-title":"Molecular prediction of clinical response to anti-PD-1\/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations","volume":"153","author":"Longuesp\u00e9e","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0685","article-title":"Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0690","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1038\/s41598-024-57714-7","article-title":"Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer","volume":"14","author":"Sun","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.04.011_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015321","article-title":"Predictive biomarkers for immunotherapy in gastric cancer: current status and emerging prospects","volume":"24","author":"Hou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2025.04.011_bb0700","article-title":"Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy","volume":"6","author":"Li","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2025.04.011_bb0705","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/17460441.2024.2370332","article-title":"The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer","volume":"19","author":"Zeng","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.trecan.2025.04.011_bb0710","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/cas.16109","article-title":"Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: a deep dive into its clinical potential","volume":"115","author":"Hashimoto","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.trecan.2025.04.011_bb0715","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.7150\/thno.98178","article-title":"Trop2-targeted therapies in solid tumors: advances and future directions","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114424","article-title":"Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.04.011_bb0725","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","article-title":"Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future","volume":"40","author":"Akhoundova","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.011_bb0730","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1002\/1878-0261.13286","article-title":"Bioinformatics roadmap for therapy selection in cancer genomics","volume":"16","author":"Jimenez-Santos","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0735","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1200\/JCO.2015.63.3651","article-title":"Biomarker: predictive or prognostic?","volume":"33","author":"Ballman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0740","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","article-title":"Predictive biomarkers in gastric cancer","volume":"149","author":"Rocken","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0745","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","article-title":"Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials","volume":"7","author":"Chao","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0750","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1200\/JCO.23.01601","article-title":"First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the Phase III CheckMate 649 trial","volume":"42","author":"Janjigian","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0755","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0760","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.011_bb0765","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2025.04.011_bb0770","unstructured":"(2024) FDA approves zolbetuximab-Clzb with chemotherapy for gastric or gastroesophageal junction adenocarcinoma."},{"key":"10.1016\/j.trecan.2025.04.011_bb0775","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","article-title":"Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry","volume":"13","author":"Mertins","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2025.04.011_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100138","article-title":"Trapped ion mobility spectrometry and parallel accumulation-serial fragmentation in proteomics","volume":"20","author":"Meier","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0785","article-title":"Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression","author":"Wang","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2025.04.011_bb0790","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10120-019-00987-z","article-title":"Report about the present condition of Billroth's stomach specimens","volume":"22","author":"Sato","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0795","first-page":"73","article-title":"History of reconstruction after total gastrectomy","volume":"42","author":"Catarci","year":"1997","journal-title":"J. R. Coll. Surg. Edinb."},{"key":"10.1016\/j.trecan.2025.04.011_bb0800","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rxeng.2022.10.011","article-title":"Gastric adenocarcinoma: a review of the TNM classification system and ways of spreading","volume":"65","author":"L\u00f3pez Sala","year":"2023","journal-title":"Radiologia (Engl. Ed.)"},{"key":"10.1016\/j.trecan.2025.04.011_bb0805","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.trecan.2025.04.011_bb0810","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2025.04.011_bb0815","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":"E-cadherin germline mutations in familial gastric cancer","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.011_bb0820","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tig.2018.05.008","article-title":"The third revolution in sequencing technology","volume":"34","author":"van Dijk","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.trecan.2025.04.011_bb0825","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.scib.2018.12.014","article-title":"Characterization and validation of somatic mutation spectrum to reveal heterogeneity in gastric cancer by single cell sequencing","volume":"64","author":"Peng","year":"2019","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.trecan.2025.04.011_bb0830","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2021.06.002","article-title":"Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients","volume":"517","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2025.04.011_bb0835","first-page":"820","article-title":"Single cell cancer epigenetics. Trends","volume":"8","author":"Casado-Pelaez","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.trecan.2025.04.011_bb0840","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2021.05.057","article-title":"Hybrid stomach-intestinal chromatin states underlie human Barrett's metaplasia","volume":"161","author":"Singh","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.04.011_bb0845","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41698-022-00251-1","article-title":"Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity","volume":"6","author":"Kim","year":"2022","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0850","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","article-title":"Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment","volume":"26","author":"Sathe","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0855","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.7150\/thno.71833","article-title":"Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0860","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/gutjnl-2021-324420","article-title":"Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition","volume":"71","author":"Sundar","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2025.04.011_bb0865","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7150\/thno.60540","article-title":"Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0870","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","article-title":"A CRISPR\/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and nonessential modes of oncogenic transformation","volume":"11","author":"Lo","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.04.011_bb0875","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41592-023-01791-5","article-title":"Single-cell proteomics enabled by next-generation sequencing or mass spectrometry","volume":"20","author":"Bennett","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2025.04.011_bb0880","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13059-021-02267-5","article-title":"Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2","volume":"22","author":"Specht","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.trecan.2025.04.011_bb0885","doi-asserted-by":"crossref","first-page":"17003","DOI":"10.1021\/acs.analchem.1c03477","article-title":"Sample size-comparable spectral library enhances data-independent acquisition-based proteome coverage of low-input cells","volume":"93","author":"Siyal","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.trecan.2025.04.011_bb0890","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12014-022-09359-9","article-title":"Optimized data-independent acquisition approach for proteomic analysis at single-cell level","volume":"19","author":"Wang","year":"2022","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.trecan.2025.04.011_bb0895","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.011_bb0900","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/gutjnl-2020-320805","article-title":"Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination","volume":"70","author":"Sundar","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2025.04.011_bb0905","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-21-0792","article-title":"Spatially distinct reprogramming of the tumor microenvironment based on tumor invasion in diffuse-type gastric cancers","volume":"27","author":"Jeong","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.011_bb0910","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1200\/JCO.1992.10.4.541","article-title":"FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer","volume":"10","author":"Kelsen","year":"1992","journal-title":"J. Clin. Oncol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:38:25Z","timestamp":1762623505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803325001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":183,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2405803325001074"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2025.04.011","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing technologies to unravel gastric cancer heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2025.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}